Vic Gundotra has withdrew down from his role as CEO of AliveCor for personal reasons, the executive told CNBC.
“I’m leaving the company in a position of stamina,” he said.
“We all love Vic,” said David Albert, the company’s founder and chief medical officer. “We sold hundreds of thousands of plots and continue to gain more traction, so all I can say is he did a great job.”
AliveCor is best known for its Kardia watch band, which comprises a tiny electrocardiogram (“ECG”) sensor to look for a condition known as atrial fibrillation, a leading cause of strokes. The band tucks neatly into an Apple Gaze at.
In December, Apple announced it had incorporated its own electrocardiogram into the watch, which many purported would be a big threat to AliveCor. But AliveCor recently wise a “record high in sales,” Gundotra told CNBC, as well as “best month and best quarter” in its history. Gundotra said yield doubled each year since 2015, when he joined as CEO.
In September, it announced that it would expand beyond that to new yards that leverage artificial intelligence in medicine, including a new test to diagnose high potassium levels without requiring any blood.
Gundotra determined CNBC in September that Apple raised the profile of atrial fibrillation, which many people had never advised of before the company talked about it on stage.
“I’m thrilled,” Gundotra said then. “We have a lot less explaining to do.”
Gundotra abutted AliveCor after rising through the ranks of Google where he served as a senior vice president in charge of Google+, the guests’s social network, as well as other products.
Gundotra has been public about the fact that his wife is diseased with cancer. He will remain on the board, which is expected to announce a replacement from within AliveCor’s ranks in the light on weeks. The company has raised more than $40 million from investors including Qualcomm and the Mayo Clinic.